Login / Signup

Relationship Between Lipoprotein(a), Renal Function Indicators, and Chronic Kidney Disease: Evidence From a Large Prospective Cohort Study.

Yingxin LiuRuoting WangShuai LiChangfa ZhangGregory Yoke Hong LipLehana ThabaneGuowei Li
Published in: JMIR public health and surveillance (2024)
The analysis revealed a significant interaction between Lp(a) and UACR in relation to CKD risk. This implies that Lp(a) may act as a risk factor for CKD even when considering UACR. Our findings have the potential to provide valuable insights into the assessment and prevention of CKD, emphasizing the combined impact of Lp(a) and UACR from a public health perspective within the general population. This could contribute to enhancing public awareness regarding the management of Lp(a) for the prevention of CKD.
Keyphrases
  • chronic kidney disease
  • end stage renal disease
  • public health
  • healthcare
  • mental health
  • risk assessment
  • adverse drug